Conantokin-G vs Plitidepsin

Head-to-head comparison of Conantokin-G (Conantokin-G from Conus geographus venom) and Plitidepsin (Dehydrodidemnin B (Plitidepsin)) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyConantokin-GPlitidepsin
CategoryExperimentalExperimental
Full NameConantokin-G from Conus geographus venomDehydrodidemnin B (Plitidepsin)
Molecular Weight2,150 Da1110.3 Da
Half-LifeMinutes to hoursApproximately 44 hours
Amino Acids17N/A
Typical Dose0.1-10 nmol intrathecal|10-1000 nM in vitro|single-dose rodent studies1.5 mg/m2 IV
RouteIntrathecalIntravenous
Purity≥98%≥98%
Studies Count95240
Research StatusPre-clinicalClinical

Conantokin-G Benefits

  • NMDA receptor antagonism
  • seizure-model research
  • excitatory neurotransmission mapping
  • pain-mechanism studies

Plitidepsin Benefits

  • antineoplastic
  • antiviral
  • pro-apoptotic
  • anti-inflammatory

Conantokin-G Dosing

Intrathecal administration in seizure/pain models|NMDA receptor assays|In vitro excitation studies

Plitidepsin Dosing

1.5 mg/m2 IV infusion in oncology trials|q21d or similar intermittent schedules|dose escalation and combination protocols in studies

Conantokin-G Side Effects

  • Sedation or dizziness in animals
  • motor effects at high exposure
  • off-target NMDA modulation

Plitidepsin Side Effects

  • nausea
  • fatigue
  • transaminase elevation

Research Overview

Conantokin-G

Research has shown conantokin-G can suppress NMDA-mediated responses in a sequence- and modification-dependent manner. It remains a classic marine peptide tool for probing glutamatergic signaling and analgesia-related pathways.

Plitidepsin

Plitidepsin has been studied for its ability to disrupt eEF1A-dependent pathways, induce oxidative stress, and suppress tumor cell growth. It has reached clinical oncology development and was also evaluated as a candidate against SARS-CoV-2 in the literature.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Conantokin-G stacks with:

ketaminememantinelamotrigine

Plitidepsin stacks with:

dexamethasonebortezomibgemcitabine
cone-snailvenom-peptidenmda-antagonistneurosciencemarine-derivedtunicatedepsipeptideanticancer